Biotronik/Aachen Lekton Vita DES Slated For Q4 2004 European Launch
Aachen Resonance will begin a randomized trial of its Tretinoin compound on Biotronik's Lekton Motion stent system early next year under a Nov. 19 pact giving Biotronik commercialization rights